UBS Knock-Out EOAN/ DE000UL4D3Q2 /
27/06/2024 21:10:37 | Chg.+0.140 | Bid- | Demandez à- | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
4.760EUR | +3.03% | - Bid taille: - |
- Ask la taille: - |
E.ON SE NA O.N. | 17.0977 EUR | 31/12/2078 | Put |
GlobeNewswire
02:48
LAKESIDE HOLDING LIMITED ANNOUNCES PRICING OF $6.75 MILLION INITIAL PUBLIC OFFERING
GlobeNewswire
02:22
CFIUS Approval Obtained for the Planned Merger of North American Stainless, Inc. and Haynes Internat...
GlobeNewswire
02:00
ROSEN, THE FIRST FILING FIRM, Encourages FutureFuel Corp. Investors to Secure Counsel Before Importa...
GlobeNewswire
01:51
ROSEN, LEADING INVESTOR COUNSEL, Encourages Gritstone bio, Inc. Investors to Secure Counsel Before I...
GlobeNewswire
01:39
“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
GlobeNewswire
01:31
PATH INVESTOR ALERT: Edelson Lechtzin LLP Urges UiPath, Inc. (NYSE: PATH) Shareholders to Consult Le...
GlobeNewswire
01:30
ROSEN, A LEADING LAW FIRM, Encourages Charge Enterprises, Inc. Investors to Secure Counsel Before Im...
GlobeNewswire
01:17
TMCF President and CEO Dr. Harry L. Williams has released the following statement on the FY25 House ...
GlobeNewswire
01:15
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Fastly, Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
01:10
Ensho Therapeutics Launches with Phase 2-Ready Oral α4β7 Inhibitor for Inflammatory Bowel Disease
GlobeNewswire
01:00
Worldwide License Agreement for EA1080, Oral Selective α4β7 Integrin Antagonist, Signed between EA P...
GlobeNewswire
00:30
Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determinatio...
GlobeNewswire
00:29
Oxford Lane Capital Corp. Prices Public Offering of $100,000,000 8.75% Notes Due 2030
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page